ArticleNature communications2026
Precise discrimination of G-quadruplex conformation by chiral nanoassembly with photo-reversibility.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
The precise detection and dynamic modulation of G-quadruplexes (G4s) are essential for elucidating their roles in gene regulation, genome stability, and disease pathogenesis. However, seldom has a photo-reversible small-molecule assembly capable of dynamically responding to G4s been reported. Here, we present a novel self-assembly strategy based on a π-extended compound, S2, which spontaneously forms functionalized helical nanoassemblies with a 51-fold enhanced chiral signal. These nanoassemblies enable S2 to discriminate parallel, antiparallel, and hybrid G4 topologies through ratiometric fluorescence and stereoselective spatial alignment. Remarkably, the S2 nanoassembly also exhibits enhanced sensitivity for RNA G4s over existing probes. Mechanistic studies reveal that this superior performance arises from a cascade response mechanism involving "assembly disruption-monomer release-fluorescence activation". Moreover, the photoisomerization capability of S2 facilitates reversible binding to parallel G4s under alternating UV/Vis irradiation. Finally, S2 is successfully used for in situ imaging of RNA G4s in live cells and for the detection of RNA G4s in clinical blood samples, enabling the differentiation between healthy individuals and lung cancer patients. This study introduces a "nanoassembly-G4 interactome" framework that extends beyond traditional ligand design paradigms, offering a valuable tool for the analysis of G4s in both biological and clinical contexts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.